Oncocyte Corporation

NASDAQ:OCX   3:59:28 PM EDT
1.03
+0.05 (+5.08%)
Earnings Announcements

OncoCyte Reports First Quarter 2022 Financial Results

Published: 05/11/2022 20:58 GMT
Oncocyte Corporation (OCX) - Oncocyte Reports First Quarter 2022 Financial Results.
Q1 Loss per Share $0.11.
Q1 Revenue $1.4 Million.
Revenue is expected to be $2.71 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $2.23 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.